CDKN2A and urothelial carcinoma: In conclusions, we demonstrated in this study a new p16 gene expression biomarker that combined both the P16 gene amplification by FISH and p16INK4a protein overexpression by immunocytochemistry to predict and diagnose urothelial carcinoma in urine cytology specimens.